Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 25 studies | 31% ± 9% | |
| fibroblast | 17 studies | 32% ± 17% | |
| smooth muscle cell | 12 studies | 21% ± 6% | |
| type I pneumocyte | 8 studies | 27% ± 9% | |
| pericyte | 8 studies | 36% ± 23% | |
| capillary endothelial cell | 7 studies | 20% ± 2% | |
| vein endothelial cell | 7 studies | 33% ± 14% | |
| astrocyte | 7 studies | 28% ± 9% | |
| basal cell | 7 studies | 22% ± 9% | |
| endothelial cell of vascular tree | 6 studies | 29% ± 17% | |
| type II pneumocyte | 6 studies | 35% ± 7% | |
| club cell | 5 studies | 35% ± 9% | |
| epithelial cell | 4 studies | 21% ± 6% | |
| adipocyte | 4 studies | 25% ± 6% | |
| endothelial cell of artery | 4 studies | 22% ± 3% | |
| ciliated cell | 4 studies | 17% ± 1% | |
| endothelial cell of lymphatic vessel | 4 studies | 25% ± 10% | |
| hepatic stellate cell | 3 studies | 35% ± 15% | |
| mesothelial cell | 3 studies | 29% ± 2% | |
| muscle cell | 3 studies | 33% ± 15% | |
| adventitial cell | 3 studies | 28% ± 8% | |
| myofibroblast cell | 3 studies | 24% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| lung | 100% | 10835.46 | 578 / 578 | 98% | 88.11 | 1128 / 1155 |
| esophagus | 98% | 5701.62 | 1423 / 1445 | 97% | 66.47 | 177 / 183 |
| uterus | 100% | 6204.84 | 170 / 170 | 90% | 42.08 | 411 / 459 |
| breast | 100% | 8989.80 | 457 / 459 | 89% | 36.92 | 993 / 1118 |
| prostate | 98% | 6472.01 | 239 / 245 | 83% | 19.99 | 415 / 502 |
| kidney | 90% | 6010.72 | 80 / 89 | 89% | 66.27 | 803 / 901 |
| ovary | 94% | 5285.93 | 170 / 180 | 82% | 25.63 | 352 / 430 |
| thymus | 100% | 6384.85 | 651 / 653 | 68% | 17.84 | 409 / 605 |
| pancreas | 65% | 2012.46 | 214 / 328 | 90% | 43.73 | 160 / 178 |
| bladder | 100% | 9012.14 | 21 / 21 | 51% | 24.36 | 256 / 504 |
| skin | 99% | 8555.70 | 1791 / 1809 | 50% | 23.41 | 236 / 472 |
| stomach | 79% | 3665.25 | 284 / 359 | 63% | 23.61 | 180 / 286 |
| adrenal gland | 100% | 7401.18 | 258 / 258 | 34% | 9.03 | 78 / 230 |
| intestine | 89% | 4880.11 | 857 / 966 | 41% | 14.84 | 215 / 527 |
| blood vessel | 100% | 10057.96 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 100% | 12340.44 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 99% | 4980.60 | 239 / 241 | 0% | 0 | 0 / 0 |
| liver | 60% | 2243.28 | 136 / 226 | 39% | 12.25 | 157 / 406 |
| tonsil | 0% | 0 | 0 / 0 | 91% | 43.99 | 41 / 45 |
| heart | 85% | 3663.94 | 729 / 861 | 0% | 0 | 0 / 0 |
| brain | 23% | 588.37 | 600 / 2642 | 43% | 16.17 | 300 / 705 |
| lymph node | 0% | 0 | 0 / 0 | 45% | 8.34 | 13 / 29 |
| muscle | 35% | 1142.50 | 283 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 20% | 2.85 | 16 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0008284 | Biological process | positive regulation of cell population proliferation |
| GO_0019221 | Biological process | cytokine-mediated signaling pathway |
| GO_0038165 | Biological process | oncostatin-M-mediated signaling pathway |
| GO_0034097 | Biological process | response to cytokine |
| GO_0002675 | Biological process | positive regulation of acute inflammatory response |
| GO_0016324 | Cellular component | apical plasma membrane |
| GO_0005900 | Cellular component | oncostatin-M receptor complex |
| GO_0009897 | Cellular component | external side of plasma membrane |
| GO_0043235 | Cellular component | receptor complex |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0019955 | Molecular function | cytokine binding |
| GO_0005127 | Molecular function | ciliary neurotrophic factor receptor binding |
| GO_0004924 | Molecular function | oncostatin-M receptor activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0004896 | Molecular function | cytokine receptor activity |
| GO_0019838 | Molecular function | growth factor binding |
| Gene name | OSMR |
| Protein name | Oncostatin M receptor Oncostatin-M-specific receptor subunit beta (Interleukin-31 receptor subunit beta) (IL-31 receptor subunit beta) (IL-31R subunit beta) (IL-31R-beta) (IL-31RB) |
| Synonyms | OSMRB |
| Description | FUNCTION: Associates with IL31RA to form the IL31 receptor. Binds IL31 to activate STAT3 and possibly STAT1 and STAT5. Capable of transducing OSM-specific signaling events. . |
| Accessions | H0Y8W9 ENST00000513831.1 ENST00000502536.5 [Q99650-2] ENST00000274276.8 [Q99650-1] H0Y9E3 Q99650 H0YAD1 ENST00000509237.5 ENST00000508882.1 |